Literature DB >> 34314730

Chemo-proteomics exploration of HDAC degradability by small molecule degraders.

Yuan Xiong1, Katherine A Donovan1, Nicholas A Eleuteri2, Nadia Kirmani2, Hong Yue1, Anthony Razov2, Noah M Krupnick2, Radosław P Nowak1, Eric S Fischer3.   

Abstract

Targeted protein degradation refers to the use of small molecules that recruit a ubiquitin ligase to a target protein for ubiquitination and subsequent proteasome-dependent degradation. While degraders have been developed for many targets, key questions regarding degrader development and the consequences of acute pharmacological degradation remain, specifically for targets that exist in obligate multi-protein complexes. Here, we synthesize a pan-histone deacetylase (HDAC) degrader library for the chemo-proteomic exploration of acute degradation of a key class of chromatin-modifying enzymes. Using chemo-proteomics, we not only map the degradability of the zinc-dependent HDAC family identifying leads for targeting HDACs 1-8 and 10 but also explore important aspects of degrading epigenetic enzymes. We discover cell line-driven target specificity and that HDAC degradation often results in collateral loss of HDAC-containing repressive complexes. These findings potentially offer a new mechanism toward controlling chromatin structure, and our resource will facilitate accelerated degrader design and development for HDACs.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  E3 ligase; HDAC; IMiD; PROTAC; collateral degradation; degrader; targeted degradation; ubiquitin

Mesh:

Substances:

Year:  2021        PMID: 34314730      PMCID: PMC9339248          DOI: 10.1016/j.chembiol.2021.07.002

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   9.039


  80 in total

1.  A fluorogenic histone deacetylase assay well suited for high-throughput activity screening.

Authors:  Dennis Wegener; Frank Wirsching; Daniel Riester; Andreas Schwienhorst
Journal:  Chem Biol       Date:  2003-01

Review 2.  Screening and profiling assays for HDACs and sirtuins.

Authors:  Konrad T Howitz
Journal:  Drug Discov Today Technol       Date:  2015-11-06

3.  Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development.

Authors:  Katherine A Donovan; Fleur M Ferguson; Jonathan W Bushman; Nicholas A Eleuteri; Debabrata Bhunia; SeongShick Ryu; Li Tan; Kun Shi; Hong Yue; Xiaoxi Liu; Dennis Dobrovolsky; Baishan Jiang; Jinhua Wang; Mingfeng Hao; Inchul You; Mingxing Teng; Yanke Liang; John Hatcher; Zhengnian Li; Theresa D Manz; Brian Groendyke; Wanyi Hu; Yunju Nam; Sandip Sengupta; Hanna Cho; Injae Shin; Michael P Agius; Irene M Ghobrial; Michelle W Ma; Jianwei Che; Sara J Buhrlage; Taebo Sim; Nathanael S Gray; Eric S Fischer
Journal:  Cell       Date:  2020-12-03       Impact factor: 41.582

Review 4.  HDACs and HDAC Inhibitors in Cancer Development and Therapy.

Authors:  Yixuan Li; Edward Seto
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity.

Authors:  Hao Wu; Ka Yang; Zhongrui Zhang; Eric D Leisten; Ziyuan Li; Haibo Xie; Jin Liu; Kerry A Smith; Zora Novakova; Cyril Barinka; Weiping Tang
Journal:  J Med Chem       Date:  2019-07-17       Impact factor: 7.446

6.  Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders.

Authors:  Shang Su; Zimo Yang; Hongying Gao; Haiyan Yang; Songbiao Zhu; Zixuan An; Juanjuan Wang; Qing Li; Sarat Chandarlapaty; Haiteng Deng; Wei Wu; Yu Rao
Journal:  J Med Chem       Date:  2019-08-02       Impact factor: 7.446

7.  An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells.

Authors:  Ekaterina V Vinogradova; Xiaoyu Zhang; David Remillard; Daniel C Lazar; Radu M Suciu; Yujia Wang; Giulia Bianco; Yu Yamashita; Vincent M Crowley; Michael A Schafroth; Minoru Yokoyama; David B Konrad; Kenneth M Lum; Gabriel M Simon; Esther K Kemper; Michael R Lazear; Sifei Yin; Megan M Blewett; Melissa M Dix; Nhan Nguyen; Maxim N Shokhirev; Emily N Chin; Luke L Lairson; Bruno Melillo; Stuart L Schreiber; Stefano Forli; John R Teijaro; Benjamin F Cravatt
Journal:  Cell       Date:  2020-07-29       Impact factor: 41.582

8.  Delineating the role of cooperativity in the design of potent PROTACs for BTK.

Authors:  Adelajda Zorba; Chuong Nguyen; Yingrong Xu; Jeremy Starr; Kris Borzilleri; James Smith; Hongyao Zhu; Kathleen A Farley; WeiDong Ding; James Schiemer; Xidong Feng; Jeanne S Chang; Daniel P Uccello; Jennifer A Young; Carmen N Garcia-Irrizary; Lara Czabaniuk; Brandon Schuff; Robert Oliver; Justin Montgomery; Matthew M Hayward; Jotham Coe; Jinshan Chen; Mark Niosi; Suman Luthra; Jaymin C Shah; Ayman El-Kattan; Xiayang Qiu; Graham M West; Mark C Noe; Veerabahu Shanmugasundaram; Adam M Gilbert; Matthew F Brown; Matthew F Calabrese
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

9.  Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis.

Authors:  Mikhail M Savitski; Nico Zinn; Maria Faelth-Savitski; Daniel Poeckel; Stephan Gade; Isabelle Becher; Marcel Muelbaier; Anne J Wagner; Katrin Strohmer; Thilo Werner; Stephanie Melchert; Massimo Petretich; Anna Rutkowska; Johanna Vappiani; Holger Franken; Michael Steidel; Gavain M Sweetman; Omer Gilan; Enid Y N Lam; Mark A Dawson; Rab K Prinjha; Paola Grandi; Giovanna Bergamini; Marcus Bantscheff
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

View more
  2 in total

1.  Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease Pathology.

Authors:  Natsuko Macabuag; William Esmieu; Perla Breccia; Rebecca Jarvis; Wesley Blackaby; Ovadia Lazari; Liudvikas Urbonas; Maria Eznarriaga; Rachel Williams; Annelieke Strijbosch; Rhea Van de Bospoort; Kim Matthews; Cole Clissold; Tammy Ladduwahetty; Huw Vater; Patrick Heaphy; Douglas G Stafford; Hong-Jun Wang; John E Mangette; George McAllister; Vahri Beaumont; Thomas F Vogt; Hilary A Wilkinson; Elizabeth M Doherty; Celia Dominguez
Journal:  J Med Chem       Date:  2022-09-13       Impact factor: 8.039

2.  Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells.

Authors:  Joshua P Smalley; India M Baker; Wiktoria A Pytel; Li-Ying Lin; Karen J Bowman; John W R Schwabe; Shaun M Cowley; James T Hodgkinson
Journal:  J Med Chem       Date:  2022-03-16       Impact factor: 8.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.